Press Releases
March 11, 2024
New partnership to develop schizophrenia treatments
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
January 09, 2024
New study paves the way for liver cirrhosis treatments
January 09, 2024
Kicking off 2024 with five new R&D partnerships
January 03, 2024
Partnership for new liver disease treatments with Ribo
November 28, 2023
Partnership with IBM to accelerate new antibody therapies
October 02, 2023
Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
May 09, 2023
IL-11 inhibitor antibody clinical development launched
January 09, 2023
New cancer therapeutics collaboration with 3T Bio
December 19, 2022
New digital Tx collab with Click
October 20, 2022
AI and Data Science Fellowship with University of Tuebingen
July 06, 2022